Related Experiment Video
Updated: Jul 30, 2026

06:41
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Hematological changes during short-term tidal flow extracorporeal life support.
G W Griffith1, J M Toomasian, R J Schreiner
1Department of General Surgery, University of Michigan Medical Center, Ann Arbor, MI, USA.
Perfusion
|December 29, 2004
Summary
A novel tidal flow system for venovenous extracorporeal life support (VV ECLS) using a single lumen cannula shows promise for long-term use. While comparable to conventional methods in preserving platelets and hemoglobin, further research is needed to address recirculation.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
- Critical Care
Background:
- Venovenous extracorporeal life support (VV ECLS) is crucial for respiratory failure.
- Current VV ECLS methods include dual-lumen catheters or separate jugular and femoral cannulation.
- Tidal flow VV ECLS offers a potential alternative using a single lumen catheter and automated occluders.
Purpose of the Study:
- To compare the efficacy and safety of a novel single-occluder tidal flow VV ECLS system with a conventional dual-lumen catheter system.
- To evaluate changes in platelet count and plasma-free hemoglobin (pHgb) during short-term VV ECLS.
Main Methods:
- A prospective study comparing a single-occluder tidal flow system (15 Fr single-lumen cannula, passive pump) with a conventional system (14 Fr dual-lumen cannula, roller pump).
- Both systems were used for four hours of VV ECLS in separate patient groups (n=6 and n=7, respectively).
- Platelet counts and plasma-free hemoglobin levels were monitored and compared between groups.
Main Results:
- Both VV ECLS systems resulted in a typical decline in platelet counts, with no significant difference between the groups.
- Plasma-free hemoglobin (pHgb) showed a slight elevation but remained within normal clinical limits (<15 mg/dL) in both groups after four hours.
- Recirculation was observed in the tidal flow system, requiring further investigation.
Conclusions:
- The single-occluder tidal flow VV ECLS system demonstrated comparable safety regarding platelet and hemoglobin levels to conventional methods.
- The system shows potential feasibility for long-term VV ECLS applications.
- Further research is necessary to resolve recirculation issues before widespread long-term clinical adoption.

